These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2872567

  • 21. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 22. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW, Leff SE, Creese I.
    Biochem Pharmacol; 1984 Mar 15; 33(6):877-87. PubMed ID: 6712712
    [Abstract] [Full Text] [Related]

  • 23. Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.
    O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL.
    Neuropharmacology; 1989 Apr 15; 28(4):401-5. PubMed ID: 2568596
    [Abstract] [Full Text] [Related]

  • 24. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G, Arnt J, Hyttel J.
    Eur J Pharmacol; 1988 Aug 24; 153(2-3):309-11. PubMed ID: 3053212
    [Abstract] [Full Text] [Related]

  • 25. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 26. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM, Waddington JL.
    Pharmacol Biochem Behav; 1990 Jan 11; 35(1):105-10. PubMed ID: 1969161
    [Abstract] [Full Text] [Related]

  • 27. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M, Adachi K, Nakamura S, Sato M, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):171-8. PubMed ID: 11448482
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P, Olianas MC.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2839-45. PubMed ID: 2820423
    [Abstract] [Full Text] [Related]

  • 29. Solubilization and reconstitution of the D-1 dopamine receptor: potentiation of the agonist high-affinity state of the receptor.
    Sidhu A.
    Biochemistry; 1988 Nov 29; 27(24):8768-76. PubMed ID: 2977287
    [Abstract] [Full Text] [Related]

  • 30. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW, Stanford EJ, Wyrick SW, Mailman RB.
    J Neurochem; 1985 Nov 29; 45(5):1601-11. PubMed ID: 2864398
    [Abstract] [Full Text] [Related]

  • 31. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB, O'Boyle KM.
    Eur J Pharmacol; 1994 Jun 15; 268(1):79-88. PubMed ID: 7925614
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the central and renal dopamine-1 receptor.
    Sidhu A, Felder RA, Jose PA, Fishman PH.
    Am J Hypertens; 1990 Jun 15; 3(6 Pt 2):37S-39S. PubMed ID: 1974441
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM, Waddington JL.
    Br J Pharmacol; 1995 Oct 15; 116(3):2120-6. PubMed ID: 8640354
    [Abstract] [Full Text] [Related]

  • 34. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat.
    Kinoshita S, Sidhu A, Felder RA.
    J Clin Invest; 1989 Dec 15; 84(6):1849-56. PubMed ID: 2574187
    [Abstract] [Full Text] [Related]

  • 35. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.
    Gottberg E, Diop L, Montreuil B, Reader TA.
    Neurochem Res; 1989 May 15; 14(5):419-26. PubMed ID: 2526301
    [Abstract] [Full Text] [Related]

  • 36. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965
    [Abstract] [Full Text] [Related]

  • 37. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O, Nielsen M, Hyttel J.
    Pharmacol Toxicol; 1987 Apr 04; 60(4):255-7. PubMed ID: 2954035
    [Abstract] [Full Text] [Related]

  • 38. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
    Battaglia G, Shannon M, Titeler M.
    J Neurochem; 1984 Nov 04; 43(5):1213-9. PubMed ID: 6491656
    [Abstract] [Full Text] [Related]

  • 39. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA.
    Brain Res; 1990 Nov 05; 532(1-2):191-6. PubMed ID: 2282513
    [Abstract] [Full Text] [Related]

  • 40. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.